NCT00588380View on ClinicalTrials.gov

GLP1R Polymorphisms and Response to GLP1

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Diabetes
Interventions
DRUG

GLP-1

GLP-1 infused at 0.75 pmol/kg/min from 121-180 minutes, GLP-1 infused at 1.55 pmol/kg/min from 181-240 minutes,

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Mayo Clinic

OTHER